Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jul 27, 2012 goldberg murray a Officer Disposition (Non Open Market) 600 n/a
Jan 26, 2012 goldberg murray a Officer Disposition (Non Open Market) 2,250 n/a
Nov 21, 2012 goldberg murray a Officer Disposition (Non Open Market) 250 n/a
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
Feb 14, 2012 mccorkle douglas s Officer Disposition (Non Open Market) 15,988 111.01
Aug 27, 2012 mccorkle douglas s Officer Disposition (Non Open Market) 256 145.23
Aug 20, 2008 roberts william Officer Disposition (Non Open Market) 10,582 21.40
Aug 22, 2008 roberts william Officer Disposition (Non Open Market) 24,102 n/a
Nov 27, 2012 roberts william Officer Disposition (Non Open Market) 11,500 n/a
Jun 13, 2013 roberts william Officer Disposition (Non Open Market) 4,000 n/a
Nov 5, 2012 roberts william Officer Disposition (Non Open Market) 26,000 n/a
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 5,812 n/a
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 3,647 n/a
Dec 12, 2008 roberts william Officer Disposition (Non Open Market) 2,400 n/a
Sep 16, 2008 roberts william Officer Disposition (Non Open Market) 15,308 21.16
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
May 16, 2014 ryan arthur f Director Disposition (Non Open Market) 2,355 n/a
May 10, 2012 ryan arthur f Director Disposition (Non Open Market) 7,000 n/a
Showing 401-420 of 897 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)